29.12.2014 Views

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

UL13.<br />

COMBINED AND SEQUENTIAL TREATMENT<br />

STRATEGIES IN DEPRESSION<br />

AND ANXIETY DISORDERS<br />

G.A. Fava<br />

Affective Disorders Program, Department of Psychology,<br />

University of Bologna, Italy<br />

There is increasing awareness that monotherapy (whether pharmacotherapy<br />

or psychotherapy) is unlikely to yield full remission in<br />

mood and anxiety disorders. The joint use of psychotherapeutic and<br />

pharmacological strategies has produced limited benefits when the<br />

two treatments have been administered simultaneously. More promising<br />

results have been obtained with their sequential combination,<br />

particularly when psychotherapeutic approaches have followed the<br />

administration of pharmacotherapy. In unipolar depression, there is<br />

substantial evidence that decreasing residual symptoms and/or<br />

increasing psychological well-being and coping skills in remitted<br />

patients may decrease relapse rate during follow-up up to 6 years. The<br />

sequential strategy does not fall within the realm of maintenance<br />

treatments. It is an intensive, 2-stage approach, which is based on the<br />

fact that addressing one dimension of illness after an earlier feature<br />

has improved can increase the likelihood of more complete and lasting<br />

remission. The planning of treatment in mood and anxiety disorders<br />

requires determination of the first line approach (e.g., pharmacotherapy)<br />

and tentative identification of other areas of concern to be<br />

addressed by concomitant or subsequent treatment.<br />

UL14.<br />

MULTIMODAL MANAGEMENT OF ANOREXIA<br />

AND BULIMIA NERVOSA<br />

K.A. Halmi<br />

Weill Medical College, Cornell University, New York, NY, USA<br />

The allostatic model is useful to conceptualize the development of the<br />

multimodal management of anorexia and bulimia nervosa. Allostasis<br />

is a dysregulation of brain reward circuits in response to the failure of<br />

homeostasis, a self-regulating process for multi system coordination<br />

of an organism’s response to an acute challenge, starvation in anorexia<br />

nervosa (AN) and binge/purge behavior in bulimia nervosa (BN).<br />

The state of allostasis reflects both genetic and environmental factors<br />

and the allostatic load represents the presence of excessive demand<br />

on regulatory systems. Multiple brain mechanisms could contribute<br />

to produce the allostatic state that underlies the severe psychopathology<br />

in anorexia and bulimia nervosa. Evidence exists for biological<br />

vulnerabilities and genetic factors leading to an allostatic state in<br />

these disorders. Dysfunction of neurotransmitters (serotonin,<br />

dopamine and norepinephrine) regulating eating behavior are present,<br />

as well as aberrations of neuropeptides (NYP, opioids, leptin,<br />

CCK, ghreline, melanocortins, adiponectin, agouti-related protein<br />

and BDNF) which affect eating. Genetic studies show significant<br />

linkage on chromosome 1 for restricting AN and on chromosome 10<br />

for BN. The key multimodal elements in the treatment of AN and BN<br />

are commensurate with the allostatic model. Medical management<br />

requires weight restoration with nutritional rehabilitation, rehydration<br />

and correction of serum electrolytes. The core eating disorder<br />

psychopathology requires specific cognitive-behavioral therapy. Adolescents<br />

with eating disorders require family therapy. Comorbidities<br />

and severe impairment of function require pharmacotherapy. Few<br />

randomized controlled treatment trials exist to provide guidelines for<br />

treatment of AN. In the past 5 years, additional family therapy studies<br />

and an olanzapine-placebo controlled trial have provided evidence<br />

for treatment of AN. In a recent trial, adolescents with BN were effectively<br />

treated with family therapy. Innovative treatments are especially<br />

needed for adults with chronic AN. Attention must be focused on<br />

resistance to treatment and extremely high dropout rates.<br />

UPDATE SYMPOSIA<br />

US1.<br />

THE EVOLVING SCIENCE AND PRACTICE<br />

OF PSYCHOSOCIAL REHABILITATION<br />

US1.1.<br />

DEVELOPMENTS IN PSYCHOSOCIAL<br />

REHABILITATION: INNOVATION OR RE-INVENTION<br />

R. Warner<br />

Department of Psychiatry, University of Colorado Health Sciences<br />

Center, Denver, CO, USA<br />

Since the Second <strong>World</strong> War, we have seen tremendous changes in<br />

psychosocial rehabilitation methods. The development of the therapeutic<br />

community, dramatic reforms in hospital care and early discharge<br />

to the community have led to the dissolution of large psychiatric<br />

institutions across the developed world. The psychosocial clubhouse<br />

has proven useful in tackling the powerlessness, boredom and<br />

social exclusion that many people with mental illness experience when<br />

they achieve a stable existence in the community. Supported employment<br />

and social firms have helped address the problem of unemployment.<br />

Cognitive behavioral therapy seeks to decrease the discomfort<br />

created by persistent psychotic symptoms, and cognitive remediation<br />

aims to reduce the handicap caused by the cognitive symptoms of psychosis.<br />

Which of these developments are truly an innovation and<br />

which are a reformulation of an earlier approach What social, political<br />

and economic factors drive the emergence of new rehabilitation<br />

methods What are the next barriers we must confront<br />

US1.2.<br />

VOCATIONAL REHABILITATION IN EUROPE:<br />

LESSONS FROM THE EQOLISE TRIAL<br />

T. Burns<br />

University of Oxford, UK<br />

The severely mentally ill invariably have low rates of employment<br />

despite extensive rehabilitation efforts. Recently there has been a shift<br />

in vocational rehabilitation in mental health, away from the more traditional<br />

structured rehabilitation programmes (often referred to as<br />

“train-and-place”) to more direct “place and train” approaches. The<br />

most widely researched of these approaches is independent placement<br />

and support (IPS) and several US randomized controlled trials<br />

have demonstrated very significant advantages over high-quality traditional<br />

rehabilitation measured as obtaining open employment.<br />

However, we have learnt from bitter experience that complex community<br />

interventions do not always work as well when translated to<br />

different social contexts, and the European employment situation is<br />

very different to that in the US. We conducted a multisite trial of IPS<br />

in Europe. The trial involved a random allocation of 302 psychotic<br />

subjects, 50 from within each of six European countries, to either IPS<br />

or local standard vocational rehabilitation. Subjects were followed up<br />

for 18 months by independent researchers. Primary outcome was<br />

7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!